Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.27 USD | -5.78% | -10.40% | +36.49% |
May. 08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
May. 08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 5.69M | Sales 2025 * | 6.25M | Capitalization | 1.96B |
---|---|---|---|---|---|
Net income 2024 * | -180M | Net income 2025 * | -206M | EV / Sales 2024 * | 291 x |
Net cash position 2024 * | 302M | Net cash position 2025 * | 122M | EV / Sales 2025 * | 294 x |
P/E ratio 2024 * |
-10.9
x | P/E ratio 2025 * |
-10.2
x | Employees | 141 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.64% |
1 day | -5.78% | ||
1 week | -10.40% | ||
Current month | -3.76% | ||
1 month | -7.40% | ||
3 months | -5.37% | ||
6 months | +83.53% | ||
Current year | +36.49% |
Managers | Title | Age | Since |
---|---|---|---|
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 15-11-30 |
Keith Regnante
DFI | Director of Finance/CFO | 54 | 20-01-31 |
Jennifer Lachey
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 20-12-16 |
Carl Gordon
CHM | Chairman | 59 | 20-02-29 |
Jasbir Seehra
CEO | Chief Executive Officer | 68 | 15-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 54.27 | -5.78% | 379,030 |
24-05-09 | 57.6 | -1.10% | 195,639 |
24-05-08 | 58.24 | -0.75% | 230,061 |
24-05-07 | 58.68 | -2.62% | 212,852 |
24-05-06 | 60.26 | -0.51% | 250,843 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.49% | 1.96B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- KROS Stock